Testing a new drug for airway problems
Part of Bones, joints & muscles, Immune system & allergy, Lungs & breathing, Skin clinical trials.
This trial tests how a drug called anti-IL-17 affects your airways. If you are already planning to take this drug, researchers want to see if it helps with breathing and airway resistance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning to start treatment with a drug called anti-IL-17
- You are not currently pregnant
- Your lung function test (spirometry) shows FEV1 of at least 1.5 liters or at least 60% of what is normal for you
- You have not had a severe allergic reaction to any medicine in the past
- Your blood pressure is under control
- You have not had a heart attack or stroke in the last 3 months
- You do not have an aortic aneurysm (a bulge in the main artery in your chest or belly)
- You have not had eye surgery recently or have a risk of high pressure inside your skull
- You have not taken corticosteroid pills or injections in the last 6 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
This trial uses advanced imaging to study the shape of airways in adults with asthma who have active symptoms and inflammation. It aims to find out if certain airway shapes affect how well treatments work, which could lead to more personalized asthma care.
This trial studies new technologies to help doctors diagnose asthma and better understand airway inflammation. It may help you (or healthy volunteers, if eligible) by allowing your breathing tests and inflammation markers to be measured with newer diagnostic tools.
This study tests a new medicine called tozorakimab for adults whose asthma is not well controlled despite using their usual inhalers. It aims to see if it can reduce asthma attacks and improve symptoms.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.